Advertisement
  • Loading metrics

Vesicular Stomatitis Virus-Based Ebola Vaccine Is Well-Tolerated and Protects Immunocompromised Nonhuman Primates

  • Thomas W. Geisbert ,

    geisbert@bu.edu

    Affiliations National Emerging Infectious Diseases Laboratories Institute, Boston, Massachusetts, United States of America, Department of Microbiology, Boston University School of Medicine, Boston, Massachusetts, United States of America, Department of Medicine, Boston University School of Medicine, Boston, Massachusetts, United States of America, Department of Pathology, Uniformed Services University of the Health Sciences, Bethesda, Maryland, United States of America, Integrated Research Facility at Fort Detrick, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America, Virology Division, BIOQUAL, Rockville, Maryland, United States of America

  • Kathleen M. Daddario-DiCaprio,

    Affiliations National Emerging Infectious Diseases Laboratories Institute, Boston, Massachusetts, United States of America, Department of Pathology, Uniformed Services University of the Health Sciences, Bethesda, Maryland, United States of America, Virology Division, BIOQUAL, Rockville, Maryland, United States of America

  • Mark G. Lewis,

    Affiliation BIOQUAL, Rockville, Maryland, United States of America

  • Joan B. Geisbert,

    Affiliations National Emerging Infectious Diseases Laboratories Institute, Boston, Massachusetts, United States of America, Virology Division, BIOQUAL, Rockville, Maryland, United States of America

  • Allen Grolla,

    Affiliation BIOQUAL, Rockville, Maryland, United States of America

  • Anders Leung,

    Affiliation Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada

  • Jason Paragas,

    Affiliation Emerging Viral Pathogens Section, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America

  • Lennox Matthias,

    Affiliation BIOQUAL, Rockville, Maryland, United States of America

  • Mark A. Smith,

    Affiliation Pathology Division, U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, Maryland, United States of America

  • Steven M. Jones,

    Affiliations Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada, Department of Immunology, University of Manitoba, Winnipeg, Manitoba, Canada, Medical Microbiology, University of Manitoba, Winnipeg, Manitoba, Canada

  • Lisa E. Hensley,

    Affiliation Virology Division, BIOQUAL, Rockville, Maryland, United States of America

  • Heinz Feldmann,

    Current address: Laboratory of Virology, Division of Intramural Research, National Institutes of Allergy and Infectious Diseases Rocky Mountain Laboratories, Hamilton, Montana, United States of America

    Affiliations Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada, Medical Microbiology, University of Manitoba, Winnipeg, Manitoba, Canada

  • Peter B. Jahrling

    Affiliations Integrated Research Facility at Fort Detrick, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America, Emerging Viral Pathogens Section, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America

Vesicular Stomatitis Virus-Based Ebola Vaccine Is Well-Tolerated and Protects Immunocompromised Nonhuman Primates

  • Thomas W. Geisbert, 
  • Kathleen M. Daddario-DiCaprio, 
  • Mark G. Lewis, 
  • Joan B. Geisbert, 
  • Allen Grolla, 
  • Anders Leung, 
  • Jason Paragas, 
  • Lennox Matthias, 
  • Mark A. Smith, 
  • Steven M. Jones
PLOS
x

Viewed info

Cited info

Saved info

Discussed info

Questions or concerns about usage data? Please let us know.